Under Jeff Marrazzo’s leadership, Spark launched world’s first FDA-approved gene therapy for a genetic disease. He also spearheaded Spark’s $4.8 billion.
Under Jeff Marrazzo's leadership, Spark launched world's first FDA-approved gene therapy for a genetic disease. He also spearheaded Spark's $4.8 billion acquisition by Roche. Company's longtime business